Clinical Trial Update: A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment [Phase 1]

View source ↗

Summary

A Phase 1 study comparing intravenous epoetin alfa products from Hospira and Amgen in chronic kidney disease patients on hemodialysis receiving epoetin maintena…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease
• Chronic Kidney Disease

Drugs mentioned

• Epoetin Hospira (epoetin alfa)
• Epogen (epoetin alfa) (epoetin alfa)

Snippet

Sponsor: Hospira, now a wholly owned subsidiary of Pfizer | Conditions: Chronic Renal Failure | Phase 1 | Status: COMPLETED